Details for New Drug Application (NDA): 212033
✉ Email this page to a colleague
The generic ingredient in NAPROXEN SODIUM is naproxen sodium; pseudoephedrine hydrochloride. There are forty-two drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the naproxen sodium; pseudoephedrine hydrochloride profile page.
Summary for 212033
Tradename: | NAPROXEN SODIUM |
Applicant: | Yichang Humanwell |
Ingredient: | naproxen sodium |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Profile for product number 001
Active Rx/OTC/Discontinued: | OTC | Dosage: | TABLET;ORAL | Strength | 220MG | ||||
Approval Date: | Aug 30, 2019 | TE: | RLD: | No |
Complete Access Available with Subscription